1 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
2 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
3 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
4 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
5 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
6 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
7 |
Lupin Atlantis Holdings SA v. Ranbaxy Laboratories Limited et al |
1:10-cv-00659 |
D.Del. |
|
|
|
|
8 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
9 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
10 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
11 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
12 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
13 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
14 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
15 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
16 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
17 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
18 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
19 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
20 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
21 |
Ranbaxy Lab Ltd, et al v. Abbott Laboratories |
1:04-cv-08078 |
N.D.Ill. |
|
|
|
|
22 |
AVENTIS PHARMACEUTICALS INC. et al v. BARR LABORATORIES, INC. |
2:04-cv-01064 |
D.N.J. |
|
|
|
|
23 |
AVENTIS PHARMACEUTICALS INC. et al v. BARR LABORATORIES, INC. |
2:04-cv-01064 |
D.N.J. |
|
|
|
|
24 |
AVENTIS PHARMACEUTICALS INC. et al v. IMPAX LABORATORIES, INC. |
2:04-cv-01076 |
D.N.J. |
|
|
|
|
25 |
AVENTIS PHARMACEUTICALS INC. et al v. IMPAX LABORATORIES, INC. |
2:04-cv-01076 |
D.N.J. |
|
|
|
|
26 |
TAKEDA CHEMICAL, et al v. RANBAXY LABORATORIES, et al |
3:03-cv-05055 |
D.N.J. |
|
|
|
|
27 |
TAKEDA CHEMICAL, et al v. RANBAXY LABORATORIES, et al |
3:03-cv-05055 |
D.N.J. |
|
|
|
|
28 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
29 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
30 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
31 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
32 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
33 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
34 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
35 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
36 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
37 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
38 |
SCHERING CORPORATION v. RANBAXY LABORATORIES, et al |
2:01-cv-02990 |
D.N.J. |
|
|
|
|